Article
Promoter accessibility within the environment of the MHC is affected in class II-deficient combined immunodeficiency.
The EMBO journal - 1 Jan 1993
Kara C J, Glimcher L H
Abstract excerpt
Class II-deficient combined immunodeficiency (CID) is a hereditary disease resulting in abrogation of transcription of the class II genes of the major histocompatibility complex, due to a defect in a trans-acting regulatory factor. Cell lines from certain CID patients lack factor binding at multiple sites in class II promoters in vivo. A mutation in one of the promoter binding proteins could explain this 'bare'...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
